Encorafenib,Binimetinib,Pembrolizumab
Pfizer,Merck,ono pharmacueticals,pierre fabre
['melanoma', 'pfizer']
see more at #aacr23 about the design of a phase 3 study evaluating an investigative combination regimen as 1l treatment in patients with unresectable locally advanced or metastatic braf v600-mutant #melanoma ct069 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ